Dragon Life Science Holdings Group, Inc.
NOHOOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$210
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Dragon Life Science Holdings Group, Inc. (NOHO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NOHO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-08 | 2020-08 | 2019-08 | 2018-08 | 2017-08 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 11.85B | 8.57B | 8.57B | 8.57B | 8.47B |
| EBITDA | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Dragon Life Science Holdings Group, Inc. data
About Dragon Life Science Holdings Group, Inc. (NOHO) Income Statement
Dragon Life Science Holdings Group, Inc. (NOHO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, NOHO reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
NOHO · 4 questionsDragon Life Science Holdings Group, Inc. (NOHO) reported revenue of $0.00B for 2021, down —% year-over-year.
NOHO revenueNOHO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09